Results 221 to 230 of about 57,983 (265)

Myopathic manifestations across the adult lifespan of patients with malignant hyperthermia susceptibility: a narrative review. [PDF]

open access: yesBr J Anaesth
Ibarra Moreno CA   +8 more
europepmc   +1 more source

Occult foreign body in bronchus masquerading clinically as malignant hyperthermia. [PDF]

open access: yesJ Anaesthesiol Clin Pharmacol
Modi D, Kaur M, Singh G, Bhatia PK.
europepmc   +1 more source

The Anesthesiologists' Perception of Malignant Hyperthermia and Availability of Dantrolene in China: A Cross-Sectional Survey. [PDF]

open access: yesRisk Manag Healthc Policy
Wang J   +12 more
europepmc   +1 more source

Turn Up the Heat: A Case Report of Malignant Hyperthermia During Ambulatory Surgery. [PDF]

open access: yesCureus
Luong A   +5 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Malignant Hyperthermia

Archives of Ophthalmology, 1983
Malignant hyperthermia, a rapidly progressive, frequently lethal syndrome was not described until quite recently. Although treatment with the drug dantrolene has changed its face, a clear understanding and deep respect for the syndrome are necessary to keep fatalities and tragic sequelae to a minimum.
T J, Blanck, R P, Gruener
  +9 more sources

Malignant Hyperthermia

Science, 1992
In humans genetically predisposed to malignant hyperthermia, anesthesia can induce skeletal muscle rigidity, hypermetabolism, and high fever, which, if not immediately reversed, can lead to tissue damage or death. The corresponding condition in swine leads to stress-induced deaths and devalued meat products. Abnormalities in the Ca
D H, MacLennan, M S, Phillips
openaire   +4 more sources

Malignant Hyperthermia

Journal of Craniofacial Surgery, 2003
Malignant Hyperthermia (MH) has been a recognized complication of general anesthesia after the first case reports in the 1940's. Since then a great deal has been discovered about the genetics, pathophysiology and treatment of this once fatal syndrome. MH is the only clinical entity specifically related to and caused by anesthetic agents.
Syed Z, Ali   +2 more
  +7 more sources

Malignant Hyperthermia

Pediatric Clinics of North America, 1994
Major advances have occurred in the management of MH since this disorder was first described. Despite the initially high mortality, deaths secondary to MH have dramatically decreased over the past 15 years, which is due in large part to the discovery of efficacious therapy.
S J, Kaus, M A, Rockoff
openaire   +2 more sources

Malignant hyperthermia

Nursing Standard, 2006
Malignant hyperthermia, also known as malignant hyperpyrexia, is a pharmacogenetic condition which can develop during general anaesthesia and can be fatal. The author suggests that more awareness of the condition is needed by ward-based nurses who are involved with patients undergoing surgery.
openaire   +4 more sources

Home - About - Disclaimer - Privacy